Pharmacist-led opioid stewardship for adults with chronic non-cancer pain
Official title: Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
Run by Korea University Guro Hospital · NCT07102446 · Data updated 2026-11-12
This program will test whether a pharmacist-led opioid stewardship program helps adults with chronic non-cancer pain reduce high-risk opioid prescriptions and improve their knowledge and attitudes about opioid use.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 79 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Korea University Guro Hospital Academic / other |
| Locations | 1 site (Seoul, Seoul) |
| Status | Recruiting |
| Started | June 27, 2025 |
| Main results expected | December 2025 |
| Study ends | June 2026 |
| Registry record updated | August 3, 2025 |
| Trial ID | NCT07102446 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 19–79 with chronic non-cancer pain who received opioid prescriptions at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine & Rehabilitation at Korea University Guro Hospital and who can give informed consent.
✕Probably not a fit
Patients with active cancer, sickle cell disease, those receiving hospice or palliative care, pregnant patients, or individuals not receiving outpatient opioid prescriptions are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, non-randomized interventional program introduces a pharmacist-led Opioid Stewardship Program (OSP) for outpatient adults with chronic non-cancer pain at Korea University Guro Hospital. The OSP includes pharmacist review of opioid prescriptions, patient education, and tailored recommendations communicated to prescribing clinicians. Outcomes from the implementation period will be compared with a historical control to measure changes in the incidence of high-risk opioid prescribing and in patients' awareness, knowledge, and attitudes about opioid use. Eligible participants are adults aged 19–79 who received specified opioid prescriptions in the designated departments during the study window.
Why it matters
Potential benefit: If successful, the program could lower high-risk opioid prescribing and improve patient safety and understanding about opioid use.
How similar studies have gone: Previous pharmacist-led opioid stewardship and multidisciplinary interventions have shown reductions in high-risk prescribing and improved patient education, so this approach has supportive precedent in the literature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Outpatients at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine \& Rehabilitation of the study site who received a prescription for opioid analgesics (oral, transdermal, sublingual, or buccal formulations containing oxycodone, fentanyl, tapentadol, hydrocodone, or morphine) due to chronic non-cancer pain during the study evaluation period (from IRB approval date to September 30, 2025) * Adults aged ≥19 years and \<80 years * Patients who voluntarily signed a written informed consent form after receiving a full explanation of the study and understanding its purpose Exclusion Criteria: * Patients with active cancer * Patients diagnosed with sickle cell disease * Patients diagnosed with a life-limiting illness eligible for hospice or palliative care as defined in Article 2 of the 'ACT ON HOSPICE AND PALLIATIVE CARE AND DECISIONS ON LIFE-SUSTAINING TREATMENT FOR PATIENTS AT THE END OF LIFE' * Pregnant patients * Patients who were prescribed opioid analgesics within the past month for postoperative pain management * Patients who were prescribed opioid analgesics within the past month for newly developed pain * Patients with communication difficulties * Patients who were prescribed buprenorphine for the treatment of opioid use disorder * Patients who are deemed inappropriate for study participation at the discretion of the investigator
Where it's running
-
Korea University Guro Hospital
Seoul, Seoul, South Korea Recruiting
Study contacts
- Principal investigator: So Hyun Lee, MS — Korea University Guro Hospital
- Study coordinator: So Hyun Lee, MS
- Email: pharm23@kumc.or.kr
- Phone: +82-2-2626-1611
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
-
Kratom and other substances safety in people with past opioid use
This study tests kratom at different doses against a placebo and oxycodone to see how people with a history of opioid use tolerate and respond to them.
-
Improving sleep and reducing opioid use in people with chronic pain
This study is testing if a sleep therapy can help people with chronic pain sleep better and use fewer opioids.
-
Comparing brain activity in women with chronic pain and opioid use to healthy women
This study looks at how brain activity differs between women with chronic pain and opioid use and healthy women to help find better treatments for pain.
-
Program to reduce opioid use in chronic pain patients after surgery
This study is testing a new program to help chronic pain patients use less opioids after surgery by providing pain education and support tools.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.